Report Detail
Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2027
- RnM2459682 |
- 10 May, 2021 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Intravenous Immunoglobulin (IVIg) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
1 Study Coverage
- 1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
- 1.4.2 IVIg Liquid
- 1.4.3 IVIg Powder
- 1.3 Market by Application
- 1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
- 1.3.2 Immunodeficiency
- 1.3.3 Autoimmune Disease
- 1.3.4 Acute Infection
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts 2016-2027
- 2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Estimates and Forecasts 2016-2027
- 2.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2016 VS 2021 VS 2027
- 2.4 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales
- 2.4.1 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales (2016-2021)
- 2.4.2 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales (2022-2027)
- 2.5 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue
- 2.5.1 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue (2016-2021)
- 2.5.2 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue (2022-2027)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
- 3.1.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales (2016-2021)
- 3.1.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers Market Share by Sales (2016-2021)
- 3.1.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Sales in 2020
- 3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
- 3.2.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (2016-2021)
- 3.2.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers Market Share by Revenue (2016-2021)
- 3.2.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Revenue in 2020
- 3.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Manufacturers
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type
- 4.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Type (2016-2021)
- 4.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Type (2022-2027)
- 4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2027)
- 4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
- 4.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Type (2016-2021)
- 4.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Type (2022-2027)
- 4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2027)
- 4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type
- 4.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
- 4.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)
5 Market Size by Application
- 5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application
- 5.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Application (2016-2021)
- 5.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Application (2022-2027)
- 5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2027)
- 5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
- 5.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Application (2016-2021)
- 5.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Application (2022-2027)
- 5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2027)
- 5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application
- 5.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
- 5.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
6 North America
- 6.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
- 6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2027)
- 6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2027)
- 6.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Application
- 6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2027)
- 6.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2027)
- 6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
- 6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2027)
- 6.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2027)
- 6.3.3 U.S.
- 6.3.4 Canada
7 Europe
- 7.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
- 7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2027)
- 7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2027)
- 7.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application
- 7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2027)
- 7.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2027)
- 7.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
- 7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2027)
- 7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2027)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type
- 8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2027)
- 8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2018-2027)
- 8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application
- 8.2.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2027)
- 8.2.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2018-2027)
- 8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region
- 8.3.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2018-2027)
- 8.3.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2018-2027)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines
9 Latin America
- 9.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Type
- 9.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2027)
- 9.1.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2027)
- 9.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Application
- 9.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2027)
- 9.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2027)
- 9.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
- 9.3.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2027)
- 9.3.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2027)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
6 Middle East and Africa
- 6.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type
- 6.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2027)
- 6.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2027)
- 6.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application
- 6.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2027)
- 6.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2027)
- 6.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
- 6.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2027)
- 6.3.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2027)
- 6.3.3 Turkey
- 6.3.4 Saudi Arabia
- 6.3.5 U.A.E
11 Company Profiles
- 11.1 Baxter
- 11.1.1 Baxter Corporation Information
- 11.1.2 Baxter Overview
- 11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Description
- 11.1.5 Baxter Related Developments
- 11.2 Grifols
- 11.2.1 Grifols Corporation Information
- 11.2.2 Grifols Overview
- 11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Description
- 11.2.5 Grifols Related Developments
- 11.3 CSL
- 11.3.1 CSL Corporation Information
- 11.3.2 CSL Overview
- 11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Description
- 11.3.5 CSL Related Developments
- 11.4 Octapharma
- 11.4.1 Octapharma Corporation Information
- 11.4.2 Octapharma Overview
- 11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Description
- 11.4.5 Octapharma Related Developments
- 11.5 Biotest
- 11.5.1 Biotest Corporation Information
- 11.5.2 Biotest Overview
- 11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Description
- 11.5.5 Biotest Related Developments
- 11.6 Kedrion
- 11.6.1 Kedrion Corporation Information
- 11.6.2 Kedrion Overview
- 11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Description
- 11.6.5 Kedrion Related Developments
- 11.7 Hualan Bio
- 11.7.1 Hualan Bio Corporation Information
- 11.7.2 Hualan Bio Overview
- 11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Description
- 11.7.5 Hualan Bio Related Developments
- 11.8 CNBG
- 11.8.1 CNBG Corporation Information
- 11.8.2 CNBG Overview
- 11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Description
- 11.8.5 CNBG Related Developments
- 11.9 Shanghai RAAS
- 11.9.1 Shanghai RAAS Corporation Information
- 11.9.2 Shanghai RAAS Overview
- 11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Description
- 11.9.5 Shanghai RAAS Related Developments
- 11.10 CBPO
- 11.10.1 CBPO Corporation Information
- 11.10.2 CBPO Overview
- 11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Description
- 11.10.5 CBPO Related Developments
- 11.1 Baxter
- 11.1.1 Baxter Corporation Information
- 11.1.2 Baxter Overview
- 11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Description
- 11.1.5 Baxter Related Developments
- 11.12 BPL
- 11.12.1 BPL Corporation Information
- 11.12.2 BPL Overview
- 11.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.12.4 BPL Product Description
- 11.12.5 BPL Related Developments
- 11.13 Sichuan Yuanda Shuyang
- 11.13.1 Sichuan Yuanda Shuyang Corporation Information
- 11.13.2 Sichuan Yuanda Shuyang Overview
- 11.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
- 11.13.4 Sichuan Yuanda Shuyang Product Description
- 11.13.5 Sichuan Yuanda Shuyang Related Developments
12 Value Chain and Sales Channels Analysis
- 12.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
- 12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
- 12.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
- 12.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
- 12.4.2 Intravenous Immunoglobulin (IVIg) Distributors
- 12.5 Intravenous Immunoglobulin (IVIg) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
- 13.2 Intravenous Immunoglobulin (IVIg) Market Drivers
- 13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
- 13.4 Intravenous Immunoglobulin (IVIg) Market Restraints
14 Key Findings in The Global Intravenous Immunoglobulin (IVIg) Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
Summary:
Get latest Market Research Reports on Intravenous Immunoglobulin (IVIg) . Industry analysis & Market Report on Intravenous Immunoglobulin (IVIg) is a syndicated market report, published as Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2027. It is complete Research Study and Industry Analysis of Intravenous Immunoglobulin (IVIg) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
